1. What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?
   Gaia Palmini et al, 2017, Molecules CrossRef
2. Overexpression of miR-506-3p reversed doxorubicin resistance in drug-resistant osteosarcoma cells
   Xinru Wang et al, 2024, Frontiers in Pharmacology CrossRef
3. Experimental pulmonary fibrosis was suppressed by microRNA-506 through NF-kappa-mediated apoptosis and inflammation
   Min Zhu et al, 2019, Cell and Tissue Research CrossRef
4. Insights into the roles of miRNAs; miR-193 as one of small molecular silencer in osteosarcoma therapy
   Sama Izadpanah et al, 2019, Biomedicine & Pharmacotherapy CrossRef
5. LINC01433 targets miR-506-3p to promote the biological progress of nasopharyngeal carcinoma cells
   Mingguang Zhou et al, 2021, European Archives of Oto-Rhino-Laryngology CrossRef
6. The absence of cellular glucose triggers oncogene AEG-1 that instigates VEGFC in HCC: A possible genetic root cause of angiogenesis
   Devan Umapathy et al, 2022, Gene CrossRef
7. Downregulation of microRNA‐124 prevents the development of acute liver failure through the upregulation of PIM‐3
   Tao Zan et al, 2020, Experimental Physiology CrossRef
8. Targeting Wnt/β-catenin signaling by microRNAs as a therapeutic approach in chemoresistant osteosarcoma
   Foroogh Hosseini et al, 2021, Biochemical Pharmacology CrossRef
9. Overexpression of microRNA-448 inhibits osteosarcoma cell proliferation and invasion through targeting of astrocyte elevated gene-1
   Weibo Jiang et al, 2017, Molecular Medicine Reports CrossRef
10. miR‑491‑5p inhibits osteosarcoma cell proliferation by targeting PKM2
    Ting Chen et al, 2018, Oncology Letters CrossRef
11. Lupeol suppresses migration and invasion via p38/MAPK and PI3K/Akt signaling pathways in human osteosarcoma U-2 OS cells
    Ming-Jie Hsu et al, 2019, Bioscience, Biotechnology, and Biochemistry CrossRef
12. miRNA signatures in childhood sarcomas and their clinical implications
    G. M. Viera et al, 2019, Clinical and Translational Oncology CrossRef
13. miRNAs as potential game-changers in bone diseases: Future medicinal and clinical uses
    Ahmed S. Doghish et al, 2023, Pathology - Research and Practice CrossRef
14. MicroRNA‐224 inhibition prevents progression of cervical carcinoma by targeting PTX3
    Li‐Mei Yu et al, 2018, Journal of Cellular Biochemistry CrossRef
15. MicroRNA‑124 acts as a tumor‑suppressive miRNA by inhibiting the expression of Snail2 in osteosarcoma
    Jianghong Huang et al, 2018, Oncology Letters CrossRef
16. MicroRNA-342-3p Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting Astrocyte-Elevated Gene-1 (AEG-1)
    Shaokun Zhang et al, 2017, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
17. miR-494 inhibits cell proliferation and metastasis via targeting of CDK6 in osteosarcoma
    Wei Yuan et al, 2017, Molecular Medicine Reports CrossRef
18. Wnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials
    Ann Neiheisel et al, 2022, International Journal of Cancer CrossRef
19. Molecular mechanism of microRNAs regulating apoptosis in osteosarcoma
    Xueyang Cai et al, 2022, Molecular Biology Reports CrossRef
20. miR‑552‑5p facilitates osteosarcoma cell proliferation and metastasis by targeting WIF1
    Wei Cai et al, 2019, Experimental and Therapeutic Medicine CrossRef
21. MiR-506 exerts antineoplastic effects on osteosarcoma cells via inhibition of the Skp2 oncoprotein
    Lu Ding et al, 2021, Aging CrossRef
22. MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression
    Wang Jiashi et al, 2018, Aging CrossRef
23. Retracted: Inhibition of microRNA‐940 suppresses the migration and invasion of human osteosarcoma cells through the secreted frizzled‐related protein 1–mediated Wnt/β‐catenin signaling pathway
    Zun‐Wen Lin et al, 2019, Journal of Cellular Biochemistry CrossRef